100 related articles for article (PubMed ID: 6890816)
1. Antitumor activity of 1-nitro-9-aminoacridine derivatives.
Hrabowska M; Mazerska Z; Lukowicz JP; Onoszko K; Ledóchowski A
Arzneimittelforschung; 1982; 32(9):1013-6. PubMed ID: 6890816
[TBL] [Abstract][Full Text] [Related]
2. A search for antitumor compounds. XI. Biologic studies. Antitumor properties of 19 new 9-aminoacridine and 1-or 3-nitro-9-aminoacridine derivatives.
Hrabowska M; Ledóchowski A; Onoszko K
Arch Immunol Ther Exp (Warsz); 1976; 24(2):249-58. PubMed ID: 1275662
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antitumor properties of nitracrine and amsacrine analogs.
Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
[TBL] [Abstract][Full Text] [Related]
4. A search for antitumor compounds. 8. Biologic studies. Antitumor properties of 17 new 1-nitro-9-aminoacridine derivatives.
Hrabowska M; Ledóchowski A; Stefańska B; Onoszko K
Arch Immunol Ther Exp (Warsz); 1970; 18(5):557-70. PubMed ID: 5493484
[No Abstract] [Full Text] [Related]
5. Search for antitumor compounds. XIII. Biological studies. Antitumor properties of 20 quinolines, carbazoles, acridines nitro derivatives.
Hrabowska M; Ledóchowski A; Wysocka-Skrzela B; Onoszko K; Paradziej-Lukowicz J
Arch Immunol Ther Exp (Warsz); 1981; 29(2):205-16. PubMed ID: 7305632
[TBL] [Abstract][Full Text] [Related]
6. A search for antitumor compounds. XII. Biologic studies. Antitumor properties of 12 new 1-nitro-9alkylaminoalkylaminoacridines.
Hrabowska M; Ledóchowski A; Onoszko K
Arch Immunol Ther Exp (Warsz); 1977; 25(2):253-62. PubMed ID: 869682
[TBL] [Abstract][Full Text] [Related]
7. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
[TBL] [Abstract][Full Text] [Related]
10. A search for antitumor compounds. VII. Biologic studies. Antitumor properties of 10 new 1-nitro-9-aminoacridine derivatives.
Hrabowska M; Ledóchowski A; Horowska B; Bogucka M; Onoszko K
Arch Immunol Ther Exp (Warsz); 1970; 18(2):230-8. PubMed ID: 5420944
[No Abstract] [Full Text] [Related]
11. Intercalation model for DNA-cross linking in a 1-nitro-9-aminoacridine derivative, an analog of the antitumor agent "ledakrin" (nitracrine).
Stallings WC; Glusker JP; Carrell HL; Bogucka-Ledóchowska M; Ledóchowski A; Stezowski JJ
J Biomol Struct Dyn; 1984 Dec; 2(3):511-24. PubMed ID: 6400911
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of antitumor properties of acridine derivatives on the basis of the results from some in vivo and in vitro tests.
Radzikowski C; Ledóchowski Z; Ledóchowski A; Wrzolek S; Hrabowska M; Konopa J
Arch Immunol Ther Exp (Warsz); 1967; 15(1):126-8. PubMed ID: 6048222
[No Abstract] [Full Text] [Related]
13. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
[TBL] [Abstract][Full Text] [Related]
14. NMR studies of configuration and tautomeric equilibria in nitroacridine antitumor agents.
Boyd M; Denny WA
J Med Chem; 1990 Sep; 33(9):2656-9. PubMed ID: 2391704
[TBL] [Abstract][Full Text] [Related]
15. 6H-pyrazolo[4,5,1-de]acridin-6-ones as a novel class of antitumor agents. Synthesis and biological activity.
Sugaya T; Mimura Y; Shida Y; Osawa Y; Matsukuma I; Ikeda S; Akinaga S; Morimoto M; Ashizawa T; Okabe M
J Med Chem; 1994 Apr; 37(7):1028-32. PubMed ID: 8151613
[TBL] [Abstract][Full Text] [Related]
16. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
17. A search for new antitumor compounds. Biological studies. 3. Antitumor properties of 14 new acridine derivatives.
Radzikowski C; Ledóchowski Z; Ledóchowski A; Peryt J; Hrabowska M; Konopa J; Balk M; Jereczek E
Arch Immunol Ther Exp (Warsz); 1967; 15(2):233-40. PubMed ID: 6050441
[No Abstract] [Full Text] [Related]
18. A search for new antitumor compounds. Biological studies. IV. Antitumor properties of 21 new acridine derivatives.
Radzikowski C; Ledóchowski Z; Ledóchowski A; Bogucka M; Hrabowska M; Konopa J; Balk M; Jereczek E
Arch Immunol Ther Exp (Warsz); 1967; 15(2):241-8. PubMed ID: 6050442
[No Abstract] [Full Text] [Related]
19. Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors.
Skladanowski A; Plisov SY; Konopa J; Larsen AK
Mol Pharmacol; 1996 May; 49(5):772-80. PubMed ID: 8622625
[TBL] [Abstract][Full Text] [Related]
20. Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide.
Rewcastle GW; Atwell GJ; Chambers D; Baguley BC; Denny WA
J Med Chem; 1986 Apr; 29(4):472-7. PubMed ID: 3959026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
